Multidose Botulinum Toxin A for Intralaryngeal Injection: A Cost Analysis

Botulinum toxin A (BtxA) injection is the mainstay treatment for laryngeal dystonias. BtxA product labeling states that reconstituted toxin should be used within 4 hours on a single patient despite several studies that have demonstrated multidose BtxA to be safe and effective. Many insurance carriers mandate the use of an outside pharmacy which necessitates a single-use approach. This study compares the cost savings of multidose BtxA for laryngeal dystonia compared to single-use.

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2E7aDcQ